Search for Clinical Trial Results
Angioedema - 87 Studies Found
Status | Study |
Completed |
Study Name: A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161 Condition: Hereditary Angioedema Date: 2014-04-24 Interventions: Drug: BCX4161 Each subject will receive Treatments A, B, and C in an open-label, randomized sequence wit |
Completed |
Study Name: First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers Condition: Hereditary Angioedema Date: 2015-05-13 Interventions:
|
Completed |
Study Name: Study to Determine How BCX4161 is Metabolized and Eliminated by the Body Condition: Hereditary Angioedema Date: 2014-08-14 Interventions: Drug: BCX4161 |
Completed |
Study Name: Patient Registry Study of Berinert® in Normal Clinical Practice Condition: Includes: Hereditary Angioedema Date: 2010-04-12 Interventions: Biological: Berinert® (C1 Esterase Inhibitor) Berinert® is marketed as a lyophilized concentra |
Active, not recruiting |
Study Name: A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions Condition: Hereditary Angioedema Date: 2017-04-24 Interventions:
|
Completed |
Study Name: An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates Condition: Hereditary Angioedema Date: 2016-06-28 Interventions: Drug: BCX7353 and probes |
Completed |
Study Name: Hereditary AngioEdema, Neurobiology and Psychopathology Condition:
Interventions: Other: Clinical and psychopathological assessment of HAE patients |
Completed |
Study Name: Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects Condition: Hereditary Angioedema (HAE) Date: 2015-12-21 Interventions:
|
Completed |
Study Name: A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects Condition: Hereditary Angioedema (HAE) Date: 2013-08-08 Interventions:
|
Completed |
Study Name: A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration Condition:
Date: 2009-02-25 Interventions: Drug: Recombinant Human C1 Inhibitor 50 IU/kg "rhC1INH", "IV" injection over 4 to 5 |